secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifevantage Corp (LFVN)
CIK:        0000849146
Form:       8-K
Filed at:   2024-04-16T23:59:59+00:00
Accession:  0000849146-24-000039
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeVantage enters $5M revolving credit facility with Bank of America, matures 2027
--------------------------------------------------------------------------------

- Revolving line of credit up to $5,000,000 with Bank of America; interest at Term SOFR + 2.00% (floor 0.00%).
- Facility matures April 12, 2027; monthly interest payments starting May 31, 2024; principal due at maturity.
- Obligations secured by substantially all assets of LifeVantage and guaranteed by subsidiary Lifeline Nutraceuticals Corporation.
- Includes up to $1,000,000 sublimit for stand-by letters of credit; 2.00% p.a. fee on undrawn amounts.
- New facility replaces prior revolving credit agreement with Zions Bancorporation, which was discharged concurrently.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/849146/000084914624000039/0000849146-24-000039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/849146/000084914624000039/lfvn-20240412.htm
  HTML page:      https://secwatch.observer/filing/0000849146-24-000039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer